HubSpot’s Launch Of ChatGPT Powered Tools Likely To Help Differentiate, Analyst Says
Piper Sandler analyst Brent Bracelin reiterates HubSpot Inc (NYSE:HUBS) with an Overweight and $450 price target. On Monday, HubSpot launched two new…
Small Cap Consumer Research Reiterates Buy on Build-A-Bear Workshop, Maintains $33 Price Target
Small Cap Consumer Research analyst Eric Beder reiterates Build-A-Bear Workshop (NYSE:BBW) with a Buy and maintains $33 price target.
EF Hutton Reiterates Buy on Adaptimmune Therapeutics, Maintains $10 Price Target
EF Hutton analyst Tony Butler reiterates Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy and maintains $10 price target.
Needham Reiterates Buy on CTI BioPharma, Maintains $9 Price Target
Needham analyst Gil Blum reiterates CTI BioPharma (NASDAQ:CTIC) with a Buy and maintains $9 price target.
Piper Sandler Reiterates Neutral on BlackLine, Maintains $64 Price Target
Piper Sandler analyst Brent Bracelin reiterates BlackLine (NASDAQ:BL) with a Neutral and maintains $64 price target.
Benchmark Reiterates Buy on Marcus, Maintains $20 Price Target
Benchmark analyst Mike Hickey reiterates Marcus (NYSE:MCS) with a Buy and maintains $20 price target.
Benchmark Reiterates Buy on Surgery Partners, Maintains $47 Price Target
Benchmark analyst Bill Sutherland reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $47 price target.
RBC Capital Reiterates Sector Perform on SolarWinds, Maintains $11 Price Target
RBC Capital analyst Matthew Hedberg reiterates SolarWinds (NYSE:SWI) with a Sector Perform and maintains $11 price target.
RBC Capital Reiterates Outperform on S&P Global, Maintains $434 Price Target
RBC Capital analyst Ashish Sabadra reiterates S&P Global (NYSE:SPGI) with a Outperform and maintains $434 price target.